Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Clinical trial NCT03162055 · COMPLETED
Trial details
- NCT number
- NCT03162055
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2018-05-04
- Enrollment
- 1119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.